AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
Migrate infobox: document_type -> document_category; add specific form as document_type
 
(3 intermediate revisions by the same user not shown)
Line 4:
| period = FY
| period_label = FY25
| document_typedocument_category = Analyst presentation
| publication_date = 2026-02-26
| language = English
Line 18:
=== Full Year 2025 earnings presentation ===
 
* '''Earnings presentation''' forAXA Full Year 2025,'' earnings presentation delivered on February 26, 2026 <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* '''Forward-looking statements''' disclaimer coversinclude predictions, planstrends, targetsplans, and expectations, specificallyor notingobjectives thatbased statements regarding expectedon Management'''underlyings earningscurrent perviews shareand (UEPS)''' growth for 2026 are forward-looking statements providing one-off guidance for the final year of the Group's currentsubject strategicto planchange <sup>p. 2</sup>.
* ''Expected UEPS growth'' for 2026 is provided as one-off guidance in the context of the final year of the Group's current strategic plan <sup>p. 2</sup>.
* '''Risk factors''' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 <sup>p. 2</sup>.
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>.
* '''Non-GAAP measures''' and alternative performance measures (APMs) used include "Underlying earnings", UEPS, "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* '''APMAlternative reconciliations'performance measures'' are(APMs) providedused ininclude AXA's"underlying Activityearnings", ReportUEPS as("underlying ofearnings Decemberper 31share"), 2025,"underlying underreturn theon headingequity", "Usecombined of non-GAAPratio", and alternative"debt performance measuresgearing" <sup>p. 2</sup>.
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by statutory auditors <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO <sup>p. 3, 4</sup>
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 3, 9</sup>
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO <sup>p. 3, 13</sup>
 
== FY25 Highlights ==
 
* '''Section divider slide for ''': FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
 
=== Full Year 2025 | Excellent performance ===
Line 46 ⟶ 47:
! class="col-m" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues growth vs. FY24
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| style="text-align:right" | +8%
|-
Line 58 ⟶ 59:
| style="text-align:right" | 224%
|-
| style="text-align:left" | Dividend per shareDPS growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | ShareAnnual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS growth targetoutlook for 2026
| style="text-align:right" | 6%Upper toend of 6%-8% (uppertarget end)range
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup>
* '''Dividend per share''' +8% growth, based on the dividend proposed by AXA's Board of Directors on February 25, 2026, subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>
 
=== Executing the plan on growth, margin and efficiency ===
Line 90:
|}
</div>
* TopHigh lineorganic growth: +6% attop constantline scope and FXgrowth, well balanced across lines: (P&C: +5%, Life: +9%, Health: +5%)
* MarginRecord profitability: Further margin expansion in P&C and L&H,; alongsideimprovement efficiencyin improvementsefficiency
* BusinessScaling scalingthe supportedbusiness: by continuedContinued investments in growth and technology
* EarningsConsistent earnings growth remained consistent while enhancing reserve prudence
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 grossGross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 120:
</div>
 
* '''Secular trends''' fuel demand across businesses, driven by protection gaps, and emerging corporate risks, andas well as demographics driving demand for private retirement and healthcare.
* '''Our right to win''' is supported by four strategic pillars:
** Leading brand & high customer NPS
** Strong and diversified distribution
Line 129:
=== Laying the foundation for the next plan ===
 
* '''Strategic pillars''' established to lay the foundation for the next plan <sup>p. 8</sup>:
** ''Clear tech'' and AI roadmap <sup>p. 8</sup>
** ''Driving efficiency'' across operations <sup>p. 8</sup>
** ''Enhancing capital'' allocation discipline <sup>p. 8</sup>
** ''Building resilience'' across the business <sup>p. 8</sup>
* '''Earnings growth'' outlook''' supported by thesestrong pillarsfoundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
 
== FY25 Business Performance ==
 
=== FY25 business performance ===
* '''Section 2''': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
=== Strong delivery across our businesses ===
 
* '''Premium growth basis''': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* '''Earnings growth basis''': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* '''Total GWP definition''': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ BusinessGross performancewritten premiums and underlying earnings by region FY25 <sup>p. 10</sup>
! style="text-align:left" | Region (share of total GWP¹)
! class="col-m" style="text-align:right" | Gross written premiums
! class="col-m" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 31bn
| class="col-m" style="text-align:right" | +7% to EUR 2.2bn
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 43bn
| class="col-m" style="text-align:right" | +9% to EUR 3.5bn
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | +4% to EUR 19bn
| class="col-m" style="text-align:right" | +9% to EUR 1.9bn
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | +13% to EUR 20bn
| class="col-m" style="text-align:right" | +6% to EUR 1.5bn
Line 173 ⟶ 175:
=== P&C | Strong margins, confidence in sustaining growth ===
 
* (donut) '''Gross written premiums''' (GWP): reached EUR 58bn total; segments include Retail, AXA XL (Large & Specialty), and SME & Mid-market (shares not labeled) <sup>p. 11</sup>.
** (donut) '''AXAGWP XL premiums'mix'': includeRetail, AXA XL Re(Large premiums& ofSpecialty), EURSME 2.6bn& Mid-market — shares not labeled <sup>p. 11</sup>.
** '''UnderlyingAXA earnings'''XL +9%GWP atincludes constantAXA FXXL toRe premiums of EUR 52.9bn6bn <sup>p. 11</sup>.
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
* '''Retail and SME''' & Mid-market strategic outlook:
* ''Retail and SME & Mid-market'' strategic outlook:
** '''2025 focus''': Growing volumes while expanding margins <sup>p. 11</sup>
** '''Beyond 2025 focus''': InvestingGrowing tovolumes improve customer retention andwhile expanding distribution footprintmargins <sup>p. 11</sup>.
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
* '''AXA XL''' (Large & Specialty) strategic outlook:
* ''AXA XL (Large & Specialty)'' strategic outlook:
** '''2025 focus''': Profitable growth with stable margins <sup>p. 11</sup>
** '''Beyond 2025 focus''': Capitalizing on attractiveProfitable growth opportunitieswith andstable continued cycle managementmargins <sup>p. 11</sup>.
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
* '''Earnings growth drivers''':
* ''Earnings drivers'' supporting performance:
** Continued progress on efficiency <sup>p. 11</sup>
** HigherContinued investmentprogress incomeon efficiency <sup>p. 11</sup>.
** Higher investment income <sup>p. 11</sup>.
** Data and AI utilization to further enhance customer experience and technical excellence <sup>p. 11</sup>
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
 
=== L&H | Good momentum, well positioned to capture growth opportunities ===
 
* (donut) '''Gross written premiums''' (GWP): reached EUR 57bn total, split by Short-term and Long-term segments (shares not labeled) <sup>p. 12</sup>.
* (donut) '''UnderlyingGWP earnings'mix'': +7%Short-term LFLand toLong-term EURsegments 3.5bn— shares not labeled <sup>p. 12</sup>.
* ''Underlying earnings'' +7% LFL to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* '''Long-term business''' strategic priorities:
* ''Long-term business'' strategic priorities:
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''Beyond 2025''': CapturingAccelerating savingsnet &flows retirementin opportunity,Savings sourcingat bestattractive asset management products for our customersmargins <sup>p. 12</sup>.
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
* '''Short-term business''' strategic priorities:
* ''Short-term business'' strategic priorities:
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''Beyond 2025''': CapitalizingGrowing ontechnical demand for health & protectionresults while furtherabsorbing improvingMexico ourVAT marginsimpact <sup>p. 12</sup>.
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
* '''Strategic enablers''':
* ''Strategic levers'' for growth and efficiency:
** Focus on cost reduction <sup>p. 12</sup>
** IncreasingFocus penetrationon ofcost Protection riders in Savings offeringsreduction <sup>p. 12</sup>.
** LeveragingIncreasing AIpenetration toof reduceProtection claimsriders leakagein &Savings improve customer outcomes in Healthofferings <sup>p. 12</sup>.
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
 
== FY25 Financial Performance ==
 
=== FY25 financial performance ===
* '''Section 3''': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
* ''Section 3'': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
Line 210 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & other revenues by segment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change LFL
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 239 ⟶ 245:
| style="text-align:right" | +2%
|-
| style="text-align:left; font-weight:bold" | Total GWP & other revenues
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
Line 247 ⟶ 253:
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>.
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>.
* Growth supported by alternative capital <sup>p. 14</sup>.
* Favorable pricing trends and strong growth in net new contracts with (+1.7m in FY25 <sup>p. 14</sup>.)
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 256 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio componentsbridge, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | Combined ratio
! class="col-s" style="text-align:right" | FY24
Line 287 ⟶ 293:
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting a favorable pricing environment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Nat Cat charges were below the normalized load <sup>p. 15</sup>
* Prior year reserve development showedshows lower reliance, taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
* Reserve prudence enhanced by taking advantage of a good year
 
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 304 ⟶ 311:
| style="text-align:right" | 5,510
|-
| style="text-align:left" | Underwriting result¹ (volumeVolume growth)
| style="text-align:right" | +292
|-
| style="text-align:left" | Underwriting result¹ (marginMargin improvement)
| style="text-align:right" | +189
|-
| style="text-align:left" | Financial result (investmentInvestment income)
| style="text-align:right" | +435
|-
| style="text-align:left" | Financial result (insuranceInsurance finance expenses)
| style="text-align:right" | -235
|-
Line 326 ⟶ 333:
|}
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m <sup>p. 16</sup>.
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>.
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>.
* Insurance finance expenses increasedimpacted fromby higher unwind of discount of claims reserves, in line with guidance <sup>p. 16</sup>.
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR <sup>p. 16</sup>.
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 336 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP & Other Revenues and Netother Flowsrevenues by segmentline, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 342 ⟶ 349:
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''Life GWP & Other Revenues'''
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
Line 367 ⟶ 374:
| style="text-align:right" | -7%
|-
| style="text-align:left" | '''Health GWP & Other Revenues'''
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
Line 382 ⟶ 389:
| style="text-align:right" | +4%
|-
| style="text-align:left" | '''Employee Benefits GWP & Other Revenues'''
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | '''Net flows'''Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
| style="text-align:right" | —
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 4.9
| style="text-align:right" | —
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" | 2.7
| style="text-align:right" | —
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | —
| style="text-align:right" | 1.5
| style="text-align:right" | —
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | —
| style="text-align:right" | 1.2
| style="text-align:right" | —
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
| style="text-align:right" | —
|}
</div>
Line 423 ⟶ 433:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP, NBtrend CSM,by NBV, and NBV marginsegment, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 429 ⟶ 439:
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | '''Total PVEP'''
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
Line 453 ⟶ 463:
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''NB CSM (pre-tax)'''
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" | '''NBV (post-tax)'''
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|-
| style="text-align:left" | '''NBV margin'''
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | —
|}
</div>
 
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales;, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 481 ⟶ 497:
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Contractual Service MarginValue
|-
| style="text-align:left" | FY24
Line 509 ⟶ 525:
</div>
 
* ''Normalized CSM'' up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
* ''Economic variance'' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
* Normalized CSM growth +2% (comprising New business CSM, Underlying return on in-force, and CSM release).
* FY24 Life segment share: EUR 25.8bn
* FY24 Health segment share: EUR 7.7bn
* FY25 Life segment share: EUR 25.4bn
* FY25 Health segment share: EUR 7.6bn
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 527 ⟶ 539:
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 542 ⟶ 554:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
 
* '''Underlying earnings''' +7% LFL to EUR 3,501m <sup>p. 20</sup>
* '''Short-term technical margin''': EUR 415m in FY24 to EUR 479m in FY25 <sup>p. 20</sup>
* '''Long-term result''' incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup>
* '''Financial result''': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>
* '''Tax & others''': EUR -748m in FY24 to EUR -728m in FY25 <sup>p. 20</sup>
* '''Life underlying earnings''' (o/w Life) grew+4% to EUR 2.7bn (+4% vs. FY24; FY24 wasprior: EUR 2.6bn) <sup>p. 20</sup>
* '''Health underlying earnings''' (o/w Health) grew+17% to EUR 0.8bn (+17% vs. FY24; FY24 wasprior: EUR 0.7bn) <sup>p. 20</sup>
* '''Short-term technical margin''' strong, reflectingon underwriting and claims initiatives that; more than offset the impact of legislative change on theMexico VAT recoverability of value added tax in Mexico of EUR -0.1bn <sup>p. 20</sup>
* '''Long-term results''' higher from increase in CSM release (increase of +8%) reflecting growth inon reserve base growth, including from favorable equity market performancemarkets, and better margins <sup>p. 20</sup>
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
 
* '''Underlying earnings''' driven by strong performance from insurance businesses <sup>p. 21</sup>
* '''Holding cost''' stable, expected to remain at current level in 2026 <sup>p. 21</sup>
* '''Net income''' increase mainly reflects higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
* '''Financial flows''' lower, reflecting unfavorable forex impact <sup>p. 21</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Earnings and net income bridgebreakdown FY24 tovs FY25 (in EUR billion) <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 592 ⟶ 599:
| style="text-align:right" | -
|-
| style="text-align:left" | '''Underlying earnings'''
| style="text-align:right" | '''8.1'''
| style="text-align:right" | '''8.4'''
| style="text-align:right" | '''+6%'''
|-
| style="text-align:left" | Non-financial flows
Line 602 ⟶ 609:
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | ''o/w capital gains from AXA IM disposal''
| style="text-align:right" | -
| style="text-align:right" | +2.2
Line 612 ⟶ 619:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | '''7.9'''
| style="text-align:right" | '''9.8'''
| style="text-align:right" | '''+26%'''
|}
</div>
 
* (bar) '''Underlying earnings per share''' (in EUR): FY24 EUR 3.59 → FY25 EUR 3.86 (+8%) <sup>p. 21</sup>
** '''Earnings growth''' contributed +6% <sup>p. 21</sup>
** '''Capital management''' contributed +3% <sup>p. 21</sup>
** '''Forex''' contributed -2% <sup>p. 21</sup>
** '''AXA IM sale''' included -1% from temporary earnings dilution due to the timing of anti-dilutive share buyback <sup>p. 21</sup>
 
=== Shareholders' Equity ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders'Underlying equityearnings (Groupper share) andbridge, otherFY24 metricsto FY25 <sup>p. 2221</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24Underlying earnings per share
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Shareholders' equity (total)FY24
| style="text-align:right" | 493.959
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
| style="text-align:left" | SHEEarnings (excl. OCI)growth
| style="text-align:right" | 58.0+6%
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | NetCapital OCImanagement
| style="text-align:right" | -8.1+3%
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)Forex
| style="text-align:right" | 53.-2%
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | DebtTemporary gearingearnings dilution from AXA IM sale
| style="text-align:right" | 20.6-1%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROEFY25
| style="text-align:right" | 153.2%86
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
* ''Underlying earnings'' drivers:
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* ''Net income'' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup>
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
 
=== Shareholders' equity ===
 
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity roll-forward (in Euro billion) <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | '''Opening Shareholders' equity'''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
Line 710 ⟶ 714:
| style="text-align:right" | 0.3
|-
| style="text-align:left" | '''Closing Shareholders' equity'''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
 
* '''Reporting currency''' is in Euro billion <sup>p. 22</sup>.
 
=== Higher organic cash remittance and robust cash position at Holding ===
 
* '(bar) ''Net cash remittance''' increased to EUR 7.5bn in FY25 <sup>p. 23</sup>trend:
** (bar) '''Net cash remittance trend'FY24'': FY24 EUR 7.7bn (total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe) → FY25 EUR 7.5bn <sup>p. 23</sup>
** '''Remittance ratio'FY25'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and: EUR 7.5bn in FY25total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge FY24 to FY25 (in Euro billion) <sup>p. 23</sup>
! style="text-align:left" | FY24EUR Cash positionbillion
! class="col-s" style="text-align:right" | 4.0
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
Line 751 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
Line 762 ⟶ 768:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Eligible Own FundsEOF
! class="col-s" style="text-align:right" | Solvency Capital RequirementSCR
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
Line 807 ⟶ 813:
|}
</div>
 
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II sensitivitiesratio as of December 31, 2025 (base ratio 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
|-
| style="text-align:left" | Interest rate +50bps
Line 829 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
Line 846 ⟶ 855:
</div>
 
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* '''Solvency II ratio''' increased to 224% in FY25 (was 216% in FY24) <sup>p. 24</sup>.
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
* '''Foreseeable dividends''' were EUR -4.8bn <sup>p. 24</sup>.
* '''Provision for share buyback''' for 2026 was EUR -1.25bn <sup>p. 24</sup>.
* Euro Sovereign spreads +50bps: (assumes 50bps spread widening of Euro sovereign bonds vs. Euro swap curve applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>
* Credit migration: (assumes 20% of corporate bonds, including private debt, held are downgraded by one full letter / 3 notches) <sup>p. 24</sup>
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 856 ⟶ 862:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio evolutionimpacts <sup>p. 25</sup>
! style="text-align:left" | Solvency II ratioEvent
! class="col-ms" style="text-align:right" | ValueImpact (pts)
|-
| style="text-align:left" | AsSolvency II ratio as of December 31, 2025
| style="text-align:right" | 224%
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10pts to 215%10
|-
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +17pts17
|}
</div>
 
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026 <sup>p. 25</sup>.
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
* No change is expected in organic capital generation <sup>p. 25</sup>.
* Provides additional capital flexibility <sup>p. 25</sup>.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusion ===
 
* '''Conclusion'Section divider'' presentedfor the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
 
=== Conclusion ===
 
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''BusinessAll performancebusinesses''' shows all businesses in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''' is well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''StrategicLaying outlookfoundations''' focused on laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* '''SessionQ&A title'session'': Q&Afor the Full Year 2025 Earnings, presentation held on February 26, 2026 <sup>p. 28</sup>.
 
=== AXA Investor Relations | Keep in touch ===
 
* '''Investor Relations contact''' details: phone +33 1 40 75 48 42, email; investor.relations@axa.com <sup>p. 29</sup>
* '''Follow us''' on: www.axa.com and social media channels <sup>p. 29</sup>
 
<div style="overflow-x:auto">
Line 930 ⟶ 938:
== Appendices ==
 
* Section divider slide for '''Appendices''' <sup>p. 30</sup>.
 
=== Table of contents ===
 
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* '''Additional P&C disclosures''' <sup>p. 36</sup>
* '''Additional IFRS17 disclosures''' <sup>p. 41</sup>
* '''Sustainability''' <sup>p. 44</sup>
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
 
<div style="overflow-x:auto">
* '''Debt gearing''' was 20.6% in FY24 and 22.3% in FY25 <sup>p. 32</sup>.
{| class="wikitable fintable"
* (stacked bar) '''Gross financial debt''' (nominal debt):
**|+ '''FY24''':Gross EUR 19.2bn total; Tier 1 EUR 4.8bn, Tier 2 EUR 10.8bn, Seniorfinancial debt EUR 3.5bn <sup>p. 32</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
** '''FY25''': EUR 20.3bn total; Tier 1 EUR 4.6bn, Tier 2 EUR 12.2bn, Senior debt EUR 3.5bn <sup>p. 32</sup>
! class="col-s" style="text-align:right" | FY24
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total; Tier 1 EUR 3.2bn, Tier 2 EUR 11.3bn, Senior debt EUR 5.8bn (of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
! class="col-s" style="text-align:right" | FY25
* (stacked bar) '''Contractual maturity breakdown''':
! class="col-s" style="text-align:right" | Jan 1st 2026
** '''2028''': Senior debt EUR 0.5bn <sup>p. 32</sup>
|-
** '''2030''': Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn <sup>p. 32</sup>
| style="text-align:left" | Tier 1
** '''2031-2039''': Senior debt EUR 1.5bn <sup>p. 32</sup>
| style="text-align:right" | 4.8
** '''>=2040''': Tier 2 EUR 10.8bn, Senior debt EUR 0.5bn <sup>p. 32</sup>
| style="text-align:right" | 4.6
** '''Undated''': Tier 1 EUR 4.6bn, Tier 2 EUR 0.7bn <sup>p. 32</sup>
| style="text-align:right" | 3.2
** '''Of which grandfathered debt''':
|-
*** '''Tier 1''': Undated EUR 1.4bn <sup>p. 32</sup>
| style="text-align:left" | Tier 2
*** '''Tier 2''': 2030 EUR 0.7bn, >=2040 EUR 0.2bn <sup>p. 32</sup>
| style="text-align:right" | 10.8
* (stacked bar) '''Economic maturity breakdown''':
| style="text-align:right" | 12.2
** '''2026''': Tier 1 EUR 0.1bn <sup>p. 32</sup>
| style="text-align:right" | 11.3
** '''2027''': Tier 2 EUR 2.4bn <sup>p. 32</sup>
|-
** '''2028''': Tier 1 EUR 0.1bn, Senior debt EUR 0.5bn <sup>p. 32</sup>
| style="text-align:left" | Senior debt
** '''2029''': Tier 2 EUR 2.0bn <sup>p. 32</sup>
| style="text-align:right" | 3.5
** '''2030''': Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn <sup>p. 32</sup>
| style="text-align:right" | 3.5
** '''2031-2039''': Tier 1 EUR 0.4bn, Tier 2 EUR 6.4bn, Senior debt EUR 1.5bn <sup>p. 32</sup>
| style="text-align:right" | 5.8
** '''>=2040''': Senior debt EUR 0.5bn <sup>p. 32</sup>
|-
** '''Undated''': Tier 1 EUR 4.0bn, Tier 2 EUR 0.7bn <sup>p. 32</sup>
| style="text-align:left; font-weight:bold" | Total
** '''Of which grandfathered debt''':
| style="text-align:right; font-weight:bold" | 19.2
*** '''Tier 1''': 2026 EUR 0.1bn, 2028 EUR 0.1bn, 2031-2039 EUR 0.4bn, Undated EUR 0.8bn <sup>p. 32</sup>
| style="text-align:right; font-weight:bold" | 20.3
*** '''Tier 2''': 2030 EUR 0.7bn, 2031-2039 EUR 0.2bn <sup>p. 32</sup>
| style="text-align:right; font-weight:bold" | 20.3
* '''Debt calls''' in January 2026: AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 5.625% issued January 2014, and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>.
|-
* '''Economic maturity definition''': Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt <sup>p. 32</sup>. For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained <sup>p. 32</sup>.
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
=== General Account invested assets ===
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2028
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
* '''Total General Account''' invested assets at EUR 450bn for FY25 <sup>p. 33</sup>
{| class="wikitable fintable"
* '''Duration gap''' at -0.4 year <sup>p. 33</sup>
|+ Economic maturity breakdown <sup>p. 32</sup>
* (donut) '''FY25 Total General Account invested assets''': EUR 450bn total; segments include Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
 
=== General account invested assets ===
 
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets (100%)breakdown in Euro billionFY25 <sup>p. 33</sup>
! style="text-align:left" | Invested assets (100%) In EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | '''Fixed income'''
| style="text-align:right" | 345
| style="text-align:right" | 77%
Line 995 ⟶ 1,156:
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income¹''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | '''Real estate'''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | '''Infrastructure equity'''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | '''Listed equities²'''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | '''Private equity and hedge funds³'''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | '''Cash'''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | '''Policy loans'''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Insurance Invested Assets⁴'Assets''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''100%'''
|}
</div>
 
=== Structured and private credit assets ===
* '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* '''Listed equities''' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
* '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
 
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
=== Structured and Private Credit assets ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and Privateprivate Creditcredit assets breakdown FY25 <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) Inin EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
Line 1,066 ⟶ 1,225:
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
Line 1,073 ⟶ 1,232:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | '''69'''
| style="text-align:right" | '''15%'''
| style="text-align:right" | o/w 54% participating
|}
</div>
 
* '''General Account''' (G/A) refersrepresents tothe Generalinvestment Accountportfolio <sup>p. 34</sup>.
 
=== Investment portfolio | Fixed Incomeincome reinvestment ===
 
<div style="overflow-x:auto">
* '''Fixed income reinvestment''' totaled EUR 57bn in FY25 <sup>p. 35</sup>
{| class="wikitable fintable"
* (donut) '''FY25 Fixed income reinvestment''' asset mix:
**|+ GovernmentFY25 bondsFixed &Income related:Reinvestment 32%asset (average rating: AA)mix <sup>p. 35</sup>
! style="text-align:left" | Asset mix
** Investment grade credit: 40% (average rating: A) <sup>p. 35</sup>
! class="col-s" style="text-align:right" | Share
** ABS/CLO/IG fund financing: 21% <sup>p. 35</sup>
|-
** Below investment grade credit: 7% <sup>p. 35</sup>
| style="text-align:left" | Government bonds & related
* (bar) '''FY25 Fixed income reinvestment yield''':
| style="text-align:right" | 32%
** Public fixed income: 3.5% <sup>p. 35</sup>
|-
** Private & Structured fixed income: 4.7% <sup>p. 35</sup>
| style="text-align:left" | Investment grade credit
** Total fixed income: 3.9% <sup>p. 35</sup>
| style="text-align:right" | 40%
* '''Reinvestment yield''' achieved at 3.9% on EUR 57bn invested <sup>p. 35</sup>:
|-
** '''Average duration''' of 9 years <sup>p. 35</sup>
| style="text-align:left" | ABS/CLO/IG fund financing
** Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
| style="text-align:right" | 21%
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Fixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | 3.9%
|}
</div>
 
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Private & Structured Credit reinvestment of EUR 19.7bn at 4.7% yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>
** Strategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
 
=== Table of contents ===
 
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup>
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,105 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business and geography <sup>p. 37</sup>
! style="text-align:left" | USDLine billionof unless otherwise mentionedbusiness
! class="col-s" style="text-align:right" | CasualtyShare
! class="col-s" style="text-align:right" | Property
! class="col-s" style="text-align:right" | Specialty
! class="col-s" style="text-align:right" | Professional lines (including Cyber)
! class="col-s" style="text-align:right" | Americas
! class="col-s" style="text-align:right" | Europe & APAC
! class="col-s" style="text-align:right" | UK & Lloyds
|-
| style="text-align:left" | FY25 GWPCasualty
| style="text-align:right" | 19
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share
| style="text-align:right" | 35%
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
 
<div style="overflow-x:auto">
* '''Market leadership''' positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
{| class="wikitable"
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
 
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* '''Cycle management''' is utilized to deliver consistent profitability <sup>p. 37</sup>:
** (bubble chart) '''Profitability vs Ex-price growth (%)'Property'': showshigh relativeprofitability, positioninghigh ofex-price key linesgrowth <sup>p. 37</sup>:
*** '''Property'Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
*** '''Specialty'Casualty'': moderate-highmedium profitability, moderatemedium ex-price growth <sup>p. 37</sup>
*** '''Casualty'Professional lines'': moderatelower profitability, moderatelower ex-price growth <sup>p. 37</sup>
*** '''Professional lines''': lower profitability, lower ex-price growth <sup>p. 37</sup>
 
=== P&C | Focus on Reservesreserves ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and Technicaltechnical reserves ratioratios <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 1,162 ⟶ 1,384:
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179%
| style="text-align:right" | 185%
| style="text-align:right" | 193%
| style="text-align:right" | 188%
| style="text-align:right" | 189%
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,176 ⟶ 1,398:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198%
| style="text-align:right" | 195%
| style="text-align:right" | 180%
| style="text-align:right" | 175%
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213%
| style="text-align:right" | 227%
| style="text-align:right" | 233%
| style="text-align:right" | 226%
| style="text-align:right" | 227%
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,196 ⟶ 1,418:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234%
| style="text-align:right" | 232%
| style="text-align:right" | 216%
| style="text-align:right" | 210%
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
=== P&C | 2026 Simplified Group Nat Cat reinsurance program 1 ===
* ¹ Includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection capacity and retention by peril <sup>p. 39</sup>
! style="text-align:left" | PerilEUR
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| class="col-s" style="text-align:right" | EUR 4.0bn600m
| class="col-s" style="text-align:right" | EUR 600m4.0bn
|-
| style="text-align:left" | Europe Flood
| class="col-s" style="text-align:right" | EUR 2.1bn450m
| class="col-s" style="text-align:right" | EUR 450m2.1bn
|-
| style="text-align:left" | Europe Earthquake
| class="col-s" style="text-align:right" | EUR 2.1bn400m
| class="col-s" style="text-align:right" | EUR 400m2.1bn
|-
| style="text-align:left" | NA Hurricane
| class="col-s" style="text-align:right" | EUR 1.2bn600m
| class="col-s" style="text-align:right" | EUR 600m1.2bn
|-
| style="text-align:left" | NA Earthquake
| class="col-s" style="text-align:right" | EUR 1.2bn600m
| class="col-s" style="text-align:right" | EUR 600m1.2bn
|-
| style="text-align:left" | Per other perils
| class="col-s" style="text-align:right" | 400m
| class="col-s" style="text-align:right" | EURVaries by peril 400mtype
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
 
* (diagram) ''Reinsurance segment'' (illustrative):
* '''Retention levels''' remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram)Covered '''Reinsurancevia segment''' (illustrative) utilizes Alternative Capital & Cat Bonds'' <sup>p. 39</sup>.
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
Line 1,247 ⟶ 1,468:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax <sup>p. 40</sup>
! style="text-align:left" | PercentileReturn period / probability percentile
! class="col-s" style="text-align:right" | EUR billion
|-
Line 1,290 ⟶ 1,511:
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
 
* '''EarningsLess deviation'severe years'' fromresult averagein Nata Catpositive chargesdeviation in 2026ca. (net60% of reinsurance, post-tax) shows asymmetric distributioncases <sup>p. 40</sup>:.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
** '''More severe years''' result in negative deviation in ca. 40% of cases <sup>p. 40</sup>.
** '''Less severe years''' result in positive deviation in ca. 60% of cases <sup>p. 40</sup>.
 
=== Table of contents ===
 
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== P&C | Margin analysis ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C Underlyingmargin Earningsanalysis Bridgeand underlying earnings FY25 <sup>p. 42</sup>
! style="text-align:left" | MetricEUR million
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''UnderlyingCurrent earningsAccident beforeYear tax'Undiscounted Technical Margin''
| class="col-s" style="text-align:right" | EUR 8,040m
| class="col-s" style="text-align:right" | +EUR 681m
|-
| style="text-align:left" | '''Tax'''
| class="col-s" style="text-align:right" | -EUR 2,060m
| class="col-s" style="text-align:right" | -EUR 169m
|-
| style="text-align:left" | '''Affiliates, minority interests & other'''
| class="col-s" style="text-align:right" | -EUR 108m
| class="col-s" style="text-align:right" | -EUR 10m
|-
| style="text-align:left" | '''Underlying earnings'''
| class="col-s" style="text-align:right" | EUR 5,872m
| class="col-s" style="text-align:right" | +EUR 501m
|-
| style="text-align:left" | '''Growth vs. FY24 (at constant FX)'''
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +9%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C margin bridge components (in EUR million, pre-tax, changes versus FY24 at constant FX) <sup>p. 42</sup>
! style="text-align:left" | Component
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | '''Current accident year undiscounted technical margin'''
| style="text-align:right" | 2,778
| style="text-align:right" | +707
| style="text-align:right" | Gross earned premiums: EUR 57,656m (+6%); Current accident year undiscounted combined ratio: 95.2% (-1.0pt); o/w Nat Cats: 3.4% (-0.4pt)
|-
| style="text-align:left" | '''Current accidentAccident yearYear discounting'Discounting''
| style="text-align:right" | 2,009
| style="text-align:right" | +115
| style="text-align:right" | Discounting ratio (in combined ratio points): -3.5% (+0.0pt); Current accident year net claims reserves: EUR 19.0bn; Duration: 4.0 years; Current accident year discount rate: 2.8%
|-
| style="text-align:left" | '''Prior yearsYears' reserveReserve developmentDevelopment (PYD)'''
| style="text-align:right" | 622
| style="text-align:right" | -341
| style="text-align:right" | PYD ratio: -1.1% (+0.7pt)
|-
| style="text-align:left" | '''Investment income'Income''
| style="text-align:right" | 3,988
| style="text-align:right" | +435
| style="text-align:right" | FY25 average assets: EUR 115bn; Asset book yield: 3.5%; FY25 reinvestment yield (on fixed income assets): 4.3%
|-
| style="text-align:left" | '''Insurance financeFinance expenses'Expenses''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:right" | FY24 reserves at locked-in rate: EUR 71bn; Liability book yield: 1.9%
| style="text-align:left" | ''Underlying Earnings before tax''
| style="text-align:right" | 8,040
| style="text-align:right" | +681
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" | ''Underlying Earnings''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|}
</div>
 
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
* ''Discounting ratio'' -3.5% (+0.0pt in Combined Ratio points) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
 
=== L&H | Margin analysis ===
 
* ''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25Technical sensitivityand tofinancial currentresults accidentin yearEuro discountmillion, rate changespre-tax <sup>p. 4243</sup>
! style="text-align:left" | ChangeTechnical inand discountFinancial rateResults
! class="col-s" style="text-align:right" | Impact (EUR billion)FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | +25bpsShort-term Technical Margin
| style="text-align:right" | +0.2479
| style="text-align:right" | +60
|-
| style="text-align:left" | Long-25bpsterm Technical Margin
| style="text-align:right" | -0.2,804
| style="text-align:right" | +156
|-
| style="text-align:left" | Investment Income (non-VFA only)
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ SensitivityUnderlying ofearnings 2026e insurance finance expenses to changesbridge in 2025 current AYEuro discountmillion <sup>p. 4243</sup>
! style="text-align:left" | ChangeUnderlying in 2025 current AY discountEarnings
! class="col-s" style="text-align:right" | Impact (EUR million)FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | +25bpsUnderlying Earnings before tax
| class="col-s" style="text-align:right" | ~-504,229
| style="text-align:right" | +205
|-
| style="text-align:left" | -25bpsTax
| class="col-s" style="text-align:right" | ~+50-800
| style="text-align:right" | 65
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|}
</div>
 
* '''TechnicalUnderlying result''' andearnings growth'''Financial result'''+7% componentsversus sumFY24 to underlying earningsat beforeconstant taxFX <sup>p. 4243</sup>.
* '''2026e insurance finance expenses''' (pre-tax): ~-EUR 1.4bn <sup>p. 42</sup>
 
=== L&H | Margin analysis ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Keykey Sensitivitiessensitivities (in Euro billion) <sup>p. 43</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact on CSM
|-
| style="text-align:left" | '''Baseline'''
| style="text-align:right" | '''33.3'''
|-
| style="text-align:left" | Interest rates +50bps
Line 1,431 ⟶ 1,684:
</div>
 
=== Table of contents ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ Life & Health Financials (pre-tax) <sup>p. 43</sup>
! style="text-align:left" | Metric
! class="col-m" style="text-align:right" | Value
! class="col-m" style="text-align:right" | LFL Change
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | '''Short-term Technical Margin'''
| class="col-m" style="text-align:right" | EUR 479m
| class="col-m" style="text-align:right" | +EUR 60m
| class="col-m" style="text-align:right" | Gross earned premiums: EUR 17,416m (+10% LFL); All year combined ratio: 97.2% (-0.1pts)
|-
| style="text-align:left" | '''Long-term Technical Margin'''
| class="col-m" style="text-align:right" | EUR 2,804m
| class="col-m" style="text-align:right" | +EUR 156m
| class="col-m" style="text-align:right" | CSM release: EUR 2,954m (+EUR 215m LFL); Technical experience: EUR -150m (-EUR 58m LFL)
|-
| style="text-align:left" | '''Investment Income (non-VFA only)'''
| class="col-m" style="text-align:right" | EUR 2,484m
| class="col-m" style="text-align:right" | -EUR 1m
| class="col-m" style="text-align:right" | Average assets: EUR 98bn; Asset book yield: 2.5%; Reinvestment yield: 3.8% on fixed income assets
|-
| style="text-align:left" | '''Insurance Finance Expenses (non-VFA only)'''
| class="col-m" style="text-align:right" | EUR -1,538m
| class="col-m" style="text-align:right" | -EUR 9m
| class="col-m" style="text-align:right" | Reserves at locked-in rate: EUR 62bn (FY24); Liability book yield: 2.5%
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| class="col-m" style="text-align:right" | EUR 4,229m
| class="col-m" style="text-align:right" | +EUR 205m
| class="col-m" style="text-align:right" | Tax: EUR -800m (+EUR 65m LFL); Affiliates, minority interests & other: EUR 72m (-EUR 51m LFL)
|-
| style="text-align:left" | '''Underlying Earnings'''
| class="col-m" style="text-align:right" | EUR 3,501m
| class="col-m" style="text-align:right" | +EUR 219m
| class="col-m" style="text-align:right" | +7% at constant FX
|}
</div>
 
* ''Debt and Invested Assets'' <sup>p. 31</sup>
=== Table of contents ===
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,477 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG Targetstargets and 2025 Resultsachievements <sup>p. 45</sup>
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025Achieved Resultin 2025
|-
| style="text-align:left" | Climate transition financing
Line 1,490 ⟶ 1,708:
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | Transition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000 (cumulative 2024-2026)
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers
Line 1,503 ⟶ 1,721:
|-
| style="text-align:left" | Climate adaptation training
| class="col-m" style="text-align:right" | >80,000 employees trained by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Carbon emissions reduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64% reduction against 2019
|-
| style="text-align:left" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees engaged by 2026
| class="col-m" style="text-align:right" | 56%
|}
Line 1,520 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG Ratings and Scoresratings <sup>p. 46</sup>
! style="text-align:left" | Rating Agency
! class="col-ms" style="text-align:right" | 2025 Score
|-
| style="text-align:left" | S&P Global percentile
| class="col-ms" style="text-align:right" | 97th percentile in Dow Jones Best-in-Class Europe & World indices
|-
| style="text-align:left" | MSCI
| class="col-ms" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-ms" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-ms" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | FTSE Russell
| class="col-ms" style="text-align:right" | 4.3/5 in FTSE4Good Index Series
|}
</div>
 
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026.
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
 
=== Scope ===
 
* '''France''' scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''' scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''' scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''' scope includes:
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; and China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) which are fully consolidated;, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other''' scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* '''Accounting standards''': Unless otherwise specified, all comparative figures going back to 2023 are under IFRS17/9 standards (effective January 1, 2023); figures prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.
 
=== Glossary ===
 
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>
* '''Contractual Service Margin (CSM)''': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup>
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>
* '''Technical experience''': consists of the impacts on the underlying earnings of (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
 
=== February 26, 2026 Thank you Full Year 2025 earnings ===
 
* ''Closing slide'' for the AXA Full Year 2025 Earnings''' presentation closing slide, dated February 26, 2026 <sup>p. 49</sup>.
 
== Abbreviations ==
 
* '''AA''': Senior bond rating
* '''AAA''': Senior bond rating
* '''ABS''': Asset-Backed Securities
* ''AEP'': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''APAC'AI'': Asia-PacificArtificial Intelligence
* '''APM'AMF'': AlternativeAutorité des Performancemarchés Measuresfinanciers
* '''AXA IM'APAC'': AXA Investment ManagersAsia-Pacific
* '''AXA XL'IM'': AXA XL (AXA's large property & casualty and specialty riskInvestment division)Managers
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* '''AY''': Accident Year
* '''BBA'AY'': Business ByAccident AccountYear
* '''CDP'BBA'': Carbon DisclosureBenefit-Bearing ProjectAccount
* '''CLO'CDP'': CollateralizedCarbon LoanDisclosure ObligationProject
* '''CRE'CLO'': CommercialCollateralized RealLoan EstateObligation
* '''CSA'CRE'': CorporateCommercial SustainabilityReal AssessmentEstate
* ''CSA'': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY'CSM'': CalendarContractual Service YearMargin
* '''EME'CY'': Europe, MiddleCalendar EastYear
* '''EOF'DPS'': EligibleDividend OwnPer FundsShare
* '''EPS'EME'': Earnings PerEmerging ShareMarkets
* ''EOF'': Eligible Own Funds
* '''ESG''': Environmental, Social, and Governance
* '''EU'EPS'': EuropeanEarnings Per UnionShare
* ''ESG'': Environmental, Social, and Governance
* '''EUR''': Euro
* ''ESMA'': European Securities and Markets Authority
* '''FTSE''': Financial Times Stock Exchange
* '''FX'EU'': ForeignEuropean ExchangeUnion
* ''EUR'': Euro
* '''GAAP''': Generally Accepted Accounting Principles
* '''GBP'FX'': Great BritishForeign PoundExchange
* ''GAAP'': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned Premiums
* '''GWP'GBP'': GrossGreat WrittenBritish PremiumsPound
* '''HKD'GEP'': HongGross KongEarned DollarPremium
* '''HY'GWP'': HighGross Written YieldPremiums
* '''IFE'HKD'': InsuranceHong FinanceKong ExpensesDollar
* ''HY'': High Yield
* '''IFRS''': International Financial Reporting Standards
* '''IG'IFE'': InvestmentInsurance Finance GradeExpenses
* ''IFRS'': International Financial Reporting Standards
* '''JPY''': Japanese Yen
* '''LATAM'IG'': LatinInvestment AmericaGrade
* '''LFL'JPY'': Like-for-LikeJapanese Yen
* '''LTV'LATAM'': Loan-to-ValueLatin America
* ''LFL'': Like-for-Like
* '''MSCI''': Morgan Stanley Capital International
* '''NA'LTV'': North AmericaLoan-to-Value
* ''MSCI'': Morgan Stanley Capital International
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV'NA'': New BusinessNorth ValueAmerica
* ''NB CSM'': New Business Contractual Service Margin
* '''NHG''': Nationale Hypotheek Garantie (National Mortgage Guarantee)
* '''NPS'NBV'': NetNew PromoterBusiness ScoreValue
* '''OCI'NHG'': OtherNationale ComprehensiveHypotheek IncomeGarantie
* '''PAA'NPS'': PremiumNet AllocationPromoter ApproachScore
* '''PE'OCI'': PrivateOther Comprehensive EquityIncome
* '''PVEP'PAA'': Present Value ofParticipating ExpectedAccount ProfitsAgreement
* ''PE'': Private Equity
* '''PYD''': Prior Years' Reserve Development
* '''RCG'PVEP'': RecurringPresent Value of CapitalExpected GainProfits
* '''ROE'PYD'': ReturnPrior Years' onReserve EquityDevelopment
* '''SCR'RCG'': SolvencyReinsurance Capital RequirementGeneration
* '''SHE'ROE'': Shareholders'Return on Equity
* '''SME'SCR'': Small andSolvency Medium-sizedCapital EnterprisesRequirement
* ''SHE'': Shareholders' Equity
* '''TVOG''': Time Value of Options & Guarantees
* ''SME'': Small and Medium-sized Enterprises
* '''UEPS''': Underlying Earnings Per Share
* ''TVOG'': Time Value of Options and Guarantees
* '''UK''': United Kingdom
* '''US'UEPS'': UnitedUnderlying Earnings Per StatesShare
* '''VAT'UK'': Value AddedUnited TaxKingdom
* '''VFA'US'': Variable FeeUnited ApproachStates
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach